Integrated Blood Pressure Control

期刊简介：This title has ceased (2024). Integrated Blood Pressure Control is an international, peer-reviewed, open-access journal focusing on the integrated approach to managing hypertension and risk reduction. Treating the patient and comorbidities together with diet and lifestyle modification and optimizing healthcare resources through a multidisciplinary team approach constitute key features of the journal. Epidemiology, screening, diagnosis, and monitoring will also be covered. Specific topics also include: Hypertension and co-existing disease Pathophysiology Risk factor modification Blood pressure monitoring programs and specific devices Treatment including pharmacological and non-pharmacological Complications of hypertension and treatment Safety Quality of Life Patient satisfaction and preference Health economic evaluations Health Policy The journal welcomes submitted papers covering original research, basic science, clinical studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports and extended reports. The main focus of the journal will be to publish research and clinical results in humans but preclinical, animal and in vitro studies will be published where they shed light on disease processes and potential new therapies and interventions. Integrated Blood Pressure Control will no longer consider meta-analyses for publication.

【译文】该头衔已终止（2024 年）。 《综合血压控制》是一本经过同行评审的国际开放获取期刊，专注于管理高血压和降低风险的综合方法。通过多学科团队的方法治疗患者和合并症、饮食和生活方式的改变以及优化医疗资源构成了该杂志的主要特色。还将涵盖流行病学、筛查、诊断和监测。具体主题还包括： 高血压和共存疾病 病理生理学 危险因素修正 血压监测方案和特定设备 治疗，包括药物和非药物高血压并发症和治疗 安全 生活质量 患者满意度和偏好 健康经济评估 健康政策 该杂志欢迎提交涵盖原始研究、基础科学、临床研究、评论和评估、指南、专家意见和评论、病例报告和扩展报告的论文。该杂志的主要重点将是发表人类研究和临床结果，但也将发表临床前、动物和体外研究，这些研究揭示了疾病过程以及潜在的新疗法和干预措施。综合血压控制将不再考虑发表荟萃分析。